Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
fluorescein (1 trial)
thymosin beta-4 (1 trial)
triamcinolone (kenalog) (1 trial)
bevacizumab (avastin) (1 trial)
ranibizumab (lucentis) (2 trials)
Dry Eye Syndromes (Phase 2)
Edema (Phase 1)
Graft vs Host Disease (Phase 2)
Keratoconjunctivitis Sicca (Phase 2)
Macular Edema (Phase 1)
Sjogren's Syndrome (Phase 2)
Trials (5 total)
Trial APIs (5 total)